Trials / Completed
CompletedNCT02835469
A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility
Non-Interventional Clinical Study on Efficacy and Safety of Highly Purified Human Menopausal Gonadotrophin (HP-hMG) Menopur® Multidose in Korean Female Patients With Infertility
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 412 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 19 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the ongoing pregnancy rates at 10-11 weeks after embryo transfer in patients treated with Menopur® Multidose
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Menotrophin |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2019-02-01
- Completion
- 2019-02-01
- First posted
- 2016-07-18
- Last updated
- 2019-03-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02835469. Inclusion in this directory is not an endorsement.